insights_auto
Why is ACRV down 10.26%?
Dive Deeperchevron_right
ACRV:NASDAQ
Acrivon Therapeutics Inc
$1.40
arrow_downward
-10.26%(-0.16) 1D
$1.40
arrow_upward
+0.31% (+0.0044)bedtimeAfter hours
Closed: Nov 19, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ACRV...
Open
$1.59
High
$1.59
Low
$1.40
Mkt. cap
60.08M
Avg. vol.
231.64K
Volume
370.88K
52-wk high
$3.55
52-wk low
$1.27
EPS
-$1.83
Beta
1.96
Shares outstanding
42.91M
No. of employees
75
Open
$1.59
High
$1.59
Low
$1.40
Mkt. cap
60.08M
Avg. vol.
231.64K
Volume
370.88K
52-wk high
$3.55
52-wk low
$1.27
EPS
-$1.83
Beta
1.96
Shares outstanding
42.91M
No. of employees
75
News stories
From web sources and news partners
kalkine.ca
·
1 day ago
Why Did Acrivon Therapeutics (NASDAQ:ACRV) Trim Nine-Month Losses to USD 54.9 Million?
Investing.com Canada
·
2 days ago
Form S-3 Acrivon Therapeutics Inc For: 17 November By Investing.com
About Acrivon Therapeutics Inc
CEO-
Employees75
Founded2018
HeadquartersWatertown, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websiteacrivon.com